How to give venofer iv dosage in adult with iron deficiency anemia
Reading File
Finding Sources
Searching PubMed
iron sucrose intravenous iron deficiency anemia dosing
Reading File
Reading File
Finding Sources
Reading File
Reading File
Reading File
Reading File
Here is a comprehensive guide to administering Venofer (iron sucrose) IV in adults with iron deficiency anemia:
Venofer (Iron Sucrose) IV — Adult Dosing Guide
Concentration
- 20 mg elemental iron per mL (100 mg/5 mL vials)
Maximum Single Dose
- 200–300 mg per session (no test dose required)
- No single infusion should exceed this limit; total iron deficit is split across multiple sessions
- No fatal anaphylactic reactions reported; no test dose needed
Administration Methods
1. Slow IV Injection (Undiluted)
| Dose | Rate |
|---|---|
| 100 mg | Over 2–5 minutes |
| 200 mg | Over 2–5 minutes |
2. IV Infusion (Diluted in NS)
| Dose | Volume | Duration |
|---|---|---|
| 100 mg | 100 mL NS | 15 minutes |
| 300 mg | 250 mL NS | 1.5 hours |
| 400 mg | 250 mL NS | 2.5 hours |
| >500 mg | 250 mL NS | 3.5 hours |
Slower infusion rates and smaller single doses are associated with fewer side effects.
Calculating Total Iron Dose (Ganzoni Formula)
Total iron dose (mg) = Body weight (kg) × [Target Hgb (g/dL) − Actual Hgb (g/dL)] × 2.4 + Iron stores (500 mg)
- Target Hgb is generally 11–12 g/dL
- The maximum daily infusion is 200 mg, so the total calculated dose is split and given every other day until repleted
Example (Creasy & Resnik's): For a 60 kg patient with Hgb 8 g/dL targeting 12 g/dL:
- (60) × (12 − 8) × 0.24 + 500 = 57.6 + 500 = ~558 mg total → given as 200 mg every other day over ~3 sessions
Indications for IV Over Oral Iron
- Poor GI absorption (IBD, malabsorption syndromes)
- Intolerance to oral preparations
- Very high iron requirements that cannot be met orally (ongoing bleeding)
- Functional iron deficiency in CKD / hemodialysis patients
- Severe anemia in 2nd/3rd trimester of pregnancy
Monitoring & Safety
- No test dose required (unlike iron dextran)
- Monitor for: hypotension, nausea, nonfatal anaphylactoid reactions (uncommon)
- Do NOT give if active infection/fever is present — increased risk of serious adverse reactions
- Delayed reactions (arthralgia, myalgia, fever, pruritus) may occur within days; usually self-limiting or treated with NSAIDs
- Wait ≥1 week before MRI after iron sucrose infusion (can interfere with liver MRI)
Comparison: Iron Sucrose vs. Newer Agents
| Drug | Max Single Dose | Notes |
|---|---|---|
| Iron sucrose (Venofer) | 200–300 mg | Multiple sessions needed |
| Ferumoxytol (Feraheme) | 510 mg | 2 doses, 7 days apart |
| Ferric carboxymaltose (Injectafer) | 750 mg | 2 doses, 7 days apart |
| Ferric derisomaltose (Monoferric) | 1000 mg | Single dose over ≥20 min |
Sources:
- Washington Manual of Medical Therapeutics (Table 21-2 IV Iron Preparations)
- Harrison's Principles of Internal Medicine 22E (Table 102-4)
- Creasy & Resnik's Maternal-Fetal Medicine
- National Kidney Foundation Primer on Kidney Diseases, 8e
- Brenner and Rector's The Kidney, 2-Volume Set
Recent evidence (2025): A systematic review and meta-analysis (PMID: 40091548, Turk J Haematol, 2025) confirmed that iron sucrose is efficacious and safe for IDA, with ferric carboxymaltose showing comparable or superior efficacy — relevant when choosing between agents in settings where single-dose high-repletion is preferred.
Patient weight 55 kgs. Hb is 5.3 gm% target hb is 12.5 now calculate dosage
Venofer Dose Calculation — Ganzoni Formula
Given:
- Weight = 55 kg
- Actual Hgb = 5.3 g/dL
- Target Hgb = 12.5 g/dL
Formula
Total iron dose (mg) = Body weight (kg) × [Target Hgb − Actual Hgb] × 2.4 + 500
Step-by-Step Calculation
| Step | Calculation | Result |
|---|---|---|
| Hgb deficit | 12.5 − 5.3 | 7.2 g/dL |
| × Body weight | 7.2 × 55 | 396 |
| × Factor 2.4 | 396 × 2.4 | 950.4 mg |
| + Iron stores | 950.4 + 500 | ≈ 1450 mg |
✅ Total Iron Required = 1450 mg
Infusion Schedule
Max single dose of Venofer = 200 mg per session (every other day)
| Session | Dose |
|---|---|
| Sessions 1–7 | 200 mg each |
| Session 8 | 50 mg (remaining) |
| Total sessions | 8 infusions |
1450 mg ÷ 200 mg = 7 full sessions + 1 session of 50 mg = 8 infusions total
Each 200 mg Infusion Preparation
- Dilute 200 mg (10 mL) in 250 mL normal saline
- Infuse over 2.5 hours
- Frequency: every other day (or as clinically feasible)
Note: With such a low Hgb (5.3 g/dL), assess for hemodynamic instability. If the patient is symptomatic or unstable, blood transfusion may be needed before or alongside IV iron therapy. IV iron alone takes weeks to fully correct hemoglobin.
Dosage of mankind iron sucrose 20mg/ml
Checking Date & Time
Mankind Iron Sucrose Injection 20 mg/mL is the same concentration as Venofer. The dosing is identical. Applying it to your patient (55 kg, Hgb 5.3, target 12.5 → total dose 1450 mg):
Mankind Iron Sucrose 20 mg/mL — Dosage
Available Vial Sizes
- 5 mL vial = 100 mg elemental iron
- 10 mL vial = 200 mg elemental iron
Per Session Preparation
Session dose: 200 mg (max per infusion)
| Step | Detail |
|---|---|
| Volume to draw | 10 mL from 20 mg/mL vial |
| Dilute in | 100–250 mL Normal Saline (0.9% NaCl) |
| Infusion rate | Over 2–2.5 hours |
| Frequency | Every other day |
Do not dilute in dextrose — iron sucrose is only stable in normal saline.
Full Course for This Patient (Total 1450 mg)
| Infusion No. | Dose | Volume to Draw |
|---|---|---|
| 1 to 7 | 200 mg each | 10 mL each |
| 8 (last) | 50 mg | 2.5 mL |
| Total | 1450 mg | 72.5 mL |
Quick Dose Reference Table
| Dose | Draw from vial | Dilute in NS | Infuse over |
|---|---|---|---|
| 100 mg | 5 mL | 100 mL | 15 min |
| 200 mg | 10 mL | 100–250 mL | 2–2.5 hours |
| 300 mg | 15 mL | 250 mL | 1.5 hours |
Key Points
- No test dose needed
- Observe patient for 30 minutes after infusion for hypersensitivity
- Do not administer if active infection/fever present
- Monitor BP during infusion (hypotension possible)
- Discard unused portion — single use only
- Check Hgb after completing the full course (typically 4 weeks after last dose)
Patient weight is 60 kgs
Using the same Hgb values (actual 5.3, target 12.5) with the new weight:
Ganzoni Formula — 60 kg Patient
| Step | Calculation | Result |
|---|---|---|
| Hgb deficit | 12.5 − 5.3 | 7.2 g/dL |
| × Body weight | 7.2 × 60 | 432 |
| × Factor 2.4 | 432 × 2.4 | 1036.8 mg |
| + Iron stores | 1036.8 + 500 | ≈ 1537 mg |
✅ Total Iron Required = 1537 mg
Infusion Schedule (Mankind Iron Sucrose 20 mg/mL, 200 mg/session)
| Infusion No. | Dose | Volume to Draw | Dilute in NS | Infuse over |
|---|---|---|---|---|
| 1 to 7 | 200 mg each | 10 mL each | 100–250 mL | 2–2.5 hrs |
| 8 (last) | 137 mg | 6.85 mL | 100 mL | ~1 hr |
| Total | 1537 mg | 76.85 mL |
1537 ÷ 200 = 7 full sessions + 1 final session of 137 mg = 8 infusions total
Summary
| Parameter | Value |
|---|---|
| Weight | 60 kg |
| Actual Hgb | 5.3 g/dL |
| Target Hgb | 12.5 g/dL |
| Total dose | 1537 mg |
| No. of infusions | 8 |
| Frequency | Every other day |
For the last session (137 mg): draw 6.85 mL (≈ 7 mL) from the 20 mg/mL vial, dilute in 100 mL NS, infuse over ~1 hour.
How many ampule to be give in single dose
Ampules Per Single Dose — Mankind Iron Sucrose 20 mg/mL
Standard Ampule Sizes Available
| Ampule | Volume | Iron Content |
|---|---|---|
| Small | 5 mL | 100 mg |
| Standard | 10 mL | 200 mg |
Single Dose = 200 mg
If using 10 mL (200 mg) ampules:
✅ 1 ampule per session
If using 5 mL (100 mg) ampules:
✅ 2 ampules per session
For This Patient (60 kg, Total 1537 mg)
| Session | Dose | Ampules (10 mL) | Ampules (5 mL) |
|---|---|---|---|
| Sessions 1–7 | 200 mg each | 1 each | 2 each |
| Session 8 (last) | 137 mg | 1 (use 6.85 mL, discard rest) | 1 full + part of 2nd |
| Total ampules needed | 8 × 10 mL ampules | 15 × 5 mL ampules |
Key Point
Each ampule is single-use only — discard any unused portion after drawing the required dose. Do not store or reuse opened ampules.
Can be given bd ??
Can Iron Sucrose (Venofer) Be Given BD (Twice Daily)?
❌ No — BD dosing is NOT recommended
Iron sucrose should not be given twice daily in the same day. Here's why:
Reasons Against BD Dosing
| Reason | Explanation |
|---|---|
| Max daily dose | 200 mg per day (single session) |
| Iron handling | The reticuloendothelial system needs time to process and transfer iron to erythroid precursors — giving it twice in one day saturates this capacity |
| Free iron toxicity | Excess unbound iron generates reactive oxygen species → oxidative damage |
| Transferrin saturation | A single 200 mg dose can transiently saturate transferrin; a second dose on the same day increases risk of free iron toxicity |
| Hypotension risk | Multiple infusions on the same day increase the risk of hypotension and infusion reactions |
✅ Correct Frequency
| Schedule | Recommendation |
|---|---|
| Standard | 200 mg on alternate days (every other day) |
| HD patients | 100 mg per dialysis session (3×/week) |
| Minimum gap | At least 24–48 hours between doses |
For Your Patient (1537 mg total)
Give 200 mg once daily on alternate days × 7 sessions, then 137 mg on the 8th session Total duration ≈ ~15–16 days
Bottom Line
BD dosing exceeds safe daily limits, risks iron overload and toxicity, and is not supported by any guideline. Always give as a single dose per session, spaced every other day.
Today a patient came for thyroid function test with raised thyroid T3 T4 very high I want to keep the aliquot of the Pateint for in house QC how to preserve the sample and how to reuse it in future ??
Reading File
Finding Sources
Searching the Web
in-house QC serum aliquot thyroid T3 T4 preservation storage freeze reuse laboratory
Finding Sources
Searching the Web
patient serum aliquot in-house QC preparation thyroid hormones freeze thaw stability cycles laboratory practice
Preserving Patient Serum Aliquot as In-House QC for Thyroid T3/T4
This is an excellent laboratory practice. Here is a complete step-by-step protocol:
Step 1 — Sample Collection & Initial Processing
| Step | Action |
|---|---|
| Tube type | Plain/SST (serum separator tube) — no anticoagulant |
| Centrifuge | 2000–3000 rpm × 10 minutes after complete clot formation |
| Separate serum | Immediately after centrifugation |
| Confirm values | Run the TFT first → confirm T3 & T4 are genuinely high (rule out interference) |
| Volume needed | Collect minimum 2–3 mL of surplus serum for QC use |
Step 2 — Aliquoting
This is the most critical step — aliquot BEFORE freezing
| Parameter | Recommendation |
|---|---|
| Aliquot volume | 200–300 µL per vial (single-use portions) |
| Tube type | Labelled cryovials (polypropylene, screw-cap) |
| Number of aliquots | Make 10–15 aliquots so each is used only once |
| Label each vial | Date, Patient ID (anonymized), analyte, level (HIGH), T3 value, T4 value |
⚠️ Never refreeze a thawed aliquot — use one vial per QC run and discard the rest
Step 3 — Storage Conditions
| Temperature | Stability Duration |
|---|---|
| 2–8°C (refrigerator) | Up to 48–72 hours only (short term) |
| −20°C (freezer) | Up to 3 months (T3, T4, TSH remain stable) |
| −70°C / −80°C (ultra-low) | Up to 3 years (FT4 confirmed stable; preferred for long-term) |
For routine in-house QC: −20°C is sufficient if used within 3 months For longer archiving, use −70°C if available
Step 4 — Freeze-Thaw Rules
| Rule | Detail |
|---|---|
| Max freeze-thaw cycles | ≤ 4 cycles (FT4 stable; T3/T4 may degrade beyond this) |
| Best practice | Single-use aliquots — thaw once, run, discard |
| Thawing method | Thaw at room temperature or 2–8°C — never in hot water or microwave |
| Mix before use | Gently invert 5–6 times after thawing — do not vortex |
Step 5 — How to Reuse in Future QC Runs
- Remove one aliquot vial from freezer
- Thaw at room temperature (~15–20 min) or overnight at 2–8°C
- Gently mix (do not vortex)
- Run alongside patient samples on your analyzer
- Record the result on your Levey-Jennings chart
- Discard the vial after use — never refreeze
- Repeat with a fresh aliquot next time
Step 6 — Documentation (Important for Accreditation)
Maintain a QC logbook with:
- Sample source date
- Assigned lot number (e.g., QC-THY-HIGH-001)
- Expected range (mean ± 2 SD after first 20 runs)
- Each run result plotted on Levey-Jennings chart
- Freeze-thaw count per vial (if reusing same vial — not recommended)
Summary Card
| Parameter | Recommendation |
|---|---|
| Aliquot size | 200–300 µL per vial |
| Storage | −20°C (≤3 months) or −70°C (≤3 years) |
| Freeze-thaw | Max 4× but ideally single use |
| Thaw method | Room temp or 2–8°C |
| Mixing | Gentle inversion — no vortex |
| After thaw | Run and discard — never refreeze |
This high-T3/T4 patient serum is a valuable pathological high-level QC material — ideal for verifying your analyzer's performance at the upper end of the reportable range.
This is a shared conversation. Sign in to Orris to start your own chat.